Amylyx Pharmaceuticals (AMLX) Revenue (2021 - 2024)
Amylyx Pharmaceuticals (AMLX) posted quarterly Revenue of -$636000.0 for Q4 2024, down 100.59% year-over-year from $108.4 million in Q1 2024, and down 252.88% quarter-over-quarter from $416000.0 in Q3 2024.
Amylyx Pharmaceuticals (AMLX) Revenue (2021 - 2024) Analysis & Trends
Amylyx Pharmaceuticals' Revenue history runs 4 years deep, the most recent figure standing at -$636000.0 for Q4 2024.
- In Q4 2024, Revenue fell 100.59% year-over-year to -$636000.0; the TTM figure through Sep 2025 stood at -$636000.0 (down 100.32% YoY), while the FY2024 annual figure was $87.4 million, down 77.05% from the prior year.
- Revenue for Q4 2024 stood at -$636000.0, down from $416000.0 in the prior quarter.
- The five-year high for Revenue was $108.4 million in Q4 2023, with the low at -$636000.0 in Q4 2024.
- The 4-year median for Revenue is $21.9 million (2022), against an average of $44.8 million.
- The sharpest annual moves came in 2023 and 2024: Revenue surged 29666.09% in 2023, then sank 100.59% in 2024.
- Amylyx Pharmaceuticals' Revenue stood at $285000.0 in 2021, then surged by 7578.95% to $21.9 million in 2022, then surged by 395.54% to $108.4 million in 2023, then tumbled by 100.59% to -$636000.0 in 2024.
- Business Quant data shows AMLX's Revenue at -$636000.0 in Q4 2024, $416000.0 in Q3 2024, and $1.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 106.20 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 1.37 Bn |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -636,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 88.64 Mn |
| Dec 31, 2023 | 108.45 Mn |
| Sep 30, 2023 | 102.69 Mn |
| Jun 30, 2023 | 98.22 Mn |
| Mar 31, 2023 | 71.43 Mn |
| Dec 31, 2022 | 21.89 Mn |
| Sep 30, 2022 | 345,000.00 |
| Sep 30, 2021 | 285,000.00 |